
Theragen Molecular Innovation Private Limited
Provides scientific research and development services in biotechnology, incorporated in 2020 in Chennai.
Provides scientific research and development services in biotechnology, incorporated in 2020 in Chennai.
Theragen Molecular Innovation Private Limited (TMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 December 2020 (Four years and five months 3 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arumugam Sivaraman, Andal Arumugam, and Chaniyilparampu Ramchand serve as directors at the Company.
Kanchipuram, Tamil Nadu, India
+91-XXXXXXXXXX
U73100TN2020PTC140124
140124
Private Limited Indian Non-Government Company
15 Dec 2020
26 Sep 2024
31 Mar 2024
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arumugam Sivaraman ![]() | Director | 15-Dec-2020 | Current |
Andal Arumugam ![]() | Director | 15-Dec-2020 | Current |
Chaniyilparampu Ramchand ![]() | Director | 15-Dec-2020 | Current |
Theragen Molecular Innovation Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2021, Theragen Molecular Innovation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Arumugam Sivaraman and Andal Arumugam are mutual person
Arumugam Sivaraman is a mutual person
Arumugam Sivaraman and Chaniyilparampu Ramchand are mutual person
Chaniyilparampu Ramchand is a mutual person
Arumugam Sivaraman is a mutual person
Arumugam Sivaraman and Andal Arumugam are mutual person
There are no open charges registered against the company as per our records.
Theragen Molecular Innovation has a workforce of 1 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Theragen Molecular Innovation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theragen Molecular Innovation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Theragen Molecular Innovation Private Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records.
Theragen Molecular Innovation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Arumugam Sivaraman was appointed as a Director was appointed as a Director on 15 Dec 2020 & has been associated with this company since 4 years 5 months .
Andal Arumugam was appointed as a Director was appointed as a Director on 15 Dec 2020 & has been associated with this company since 4 years 5 months .
Chaniyilparampu Nanappan Ramchand was appointed as a Director was appointed as a Director on 15 Dec 2020 & has been associated with this company since 4 years 5 months .
Theragen Molecular Innovation Private Limited was registered on 15 Dec 2020 with Roc Chennai & aged 4 years 5 months as per MCA records.
Theragen Molecular Innovation Private Limited was incorporated on 15 Dec 2020.
The authorized share capital of Theragen Molecular Innovation Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Theragen Molecular Innovation Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Theragen Molecular Innovation Private Limited is No.153 1St Main Road, Industrial Estate Perungudi India, Chennai, Tamil Nadu, 600096.
The corporate identification number (CIN) of Theragen Molecular Innovation Private Limited is U73100TN2020PTC140124 and the company number is 140124 as per Ministry of Corporate Affairs (MCA).
As Per 2021 financial reports, 1 employees are currently employed by Theragen Molecular Innovation Private Limited.
The most recent Balance Sheet for Theragen Molecular Innovation Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.